Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Lydie Hazan

Beverly Hills, CA Medical Doctor

NPI 1215013446 CMS profile 235950

8500 Wilshire Blvd, #700, Beverly Hills, CA 90211

Open in the dashboard

General payments

$3,870

24 records reported · program years 2019–2023

Research payments

$346,826

Paid to them · 3 records reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,933,248 paid to institutions, not to them · program years 2019–2023

Through program year 2023, Lydie Hazan of Beverly Hills, CA is reported in the CMS Open Payments database as having received $3,870 across 24 general payments and $346,826 in research payments paid to them. Separately, studies naming them as principal investigator received $1,933,248 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $108 1
2022 General $28 1
2019 General $3,734 22
2019 Research $346,826 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lydie Hazan
  • California median
  • Middle half of California
  • National median

In program year 2025, general payments to Lydie Hazan were reported at $0. Among 98,626 California profiles paid that year, the median was $172 and the middle half received between $54 and $610.

Show as a table
Year Lydie Hazan California median Middle half National median
2019 $3,734 $161 $50–$652 $163
2020 $0 $114 $34–$392 $114
2021 $0 $137 $41–$509 $132
2022 $28 $152 $48–$573 $149
2023 $108 $162 $50–$581 $160
2024 $0 $162 $52–$583 $164
2025 $0 $172 $54–$610 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Eisai Inc. $1,266 11 payments
  2. Horizon Therapeutics plc $1,228 8 payments
  3. Celltrion, Inc. $1,023 1 payment
  4. AstraZeneca Pharmaceuticals LP $117 1 payment
  5. Sanofi Pasteur Inc. $108 1 payment
  6. Navidea Biopharmaceuticals, Inc. $100 1 payment
  7. Visby Medical, Inc. $28 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Travel and Lodging $1,954 8 payments
  2. Consulting Fee $1,023 1 payment
  3. Food and Beverage $894 15 payments
Products named General payments · program years 2019–2023
  1. Belviq $1,266 11 payments
  2. KRYSTEXXA $1,228 8 payments
  3. Visby Medical Sexual Health Click Test $28 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2023
  1. Eli Lilly and Company $318,026 2 payments
  2. Celltrion, Inc. $28,800 1 payment

Records

27 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record